Adding thymoglobuline to the conventional immunosuppressant regimen in kidney transplantation: a cost-benefit analysis

Authors
Category Primary study
Year 2012
This is an economic evaluation that meets the criteria for inclusion on NHS EED.
Epistemonikos ID: ca211fec5f62ed45176178e23f1c7fd351e2bdac
First added on: Apr 19, 2023